Venous thromboembolism is a common complication of asparaginase-based chemotherapy regimens for the treatment of acute lymphoblastic leukemia. Thrombosis associated with asparaginase administration poses a number of specific and often clinically challenging management decisions. This review provides guidance on the prevention and treatment of thrombosis associated with asparaginase in adults including discussions on antithrombin repletion, pharmacologic thromboprophylaxis, cerebral venous thrombosis, and therapeutic anticoagulation.

Additional Metadata
Keywords acute lymphoblastic leukemia, anticoagulation, antithrombin, asparaginase, cerebral venous thrombosis, venous thromboembolism
Persistent URL dx.doi.org/10.1111/jth.14671, hdl.handle.net/1765/124336
Journal Journal of Thrombosis and Haemostasis
Citation
Zwicker, J.I. (Jeffrey I.), Wang, T.-F. (Tzu-Fei), DeAngelo, D.J. (Daniel J.), Lauw, I, Connors, J.M. (Jean M.), Falanga, A. (Anna), … Carrier, M. (Marc). (2020). The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH. Journal of Thrombosis and Haemostasis, 18(2), 278–284. doi:10.1111/jth.14671